The HemOnc Pulse

The HemOnc Pulse


What are the Controversies Surrounding MRD in Blood Cancers?

April 25, 2024

On this episode of "The HemOnc Pulse," Alan Skarbnik, MD, of Novant Health, and Manni Mohyuddin, MBBS, of the University of Utah, discuss the concept of measurable residual disease (MRD) in hematologi